As patients with severe COVID-19 have an increased inflammatory response that depletes arginine, and subsequently impairs T cell function, inhibition of arginase-1 and/or replenishment of arginine may be a potential future therapeutic approach in preventing/treating severe COVID-19 (75). Here, ARG1 is linked to COVID-19.